PubRank
Search
About
Hélène Jacqmin-Gadda
Author PubWeight™ 37.24
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Ann Neurol
2008
4.07
2
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.
Brain
2005
2.51
3
Mixed models for longitudinal left-censored repeated measures.
Comput Methods Programs Biomed
2004
2.23
4
Bivariate linear mixed models using SAS proc MIXED.
Comput Methods Programs Biomed
2002
1.87
5
Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies.
Am J Epidemiol
2006
1.48
6
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks.
Stat Med
2013
1.48
7
Normalized Mini-Mental State Examination for assessing cognitive change in population-based brain aging studies.
Neuroepidemiology
2014
1.39
8
Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection.
Stat Med
2005
1.38
9
Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events.
Biostatistics
2007
1.38
10
Joint latent class models for longitudinal and time-to-event data: a review.
Stat Methods Med Res
2012
1.34
11
A nonlinear latent class model for joint analysis of multivariate longitudinal data and a binary outcome.
Stat Med
2007
1.20
12
A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data.
Biometrics
2006
1.12
13
Estimation of dynamical model parameters taking into account undetectable marker values.
BMC Med Res Methodol
2006
1.08
14
Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
Brain
2014
1.08
15
Gender and education impact on brain aging: a general cognitive factor approach.
Psychol Aging
2008
1.01
16
Misuse of the linear mixed model when evaluating risk factors of cognitive decline.
Am J Epidemiol
2011
0.98
17
Cardiovascular mortality and calcium and magnesium in drinking water: an ecological study in elderly people.
Eur J Epidemiol
2003
0.98
18
Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort.
Am J Epidemiol
2008
0.95
19
Ten-year change in disability prevalence and related factors in two generations of French elderly community dwellers: data from the PAQUID study.
Aging Clin Exp Res
2005
0.92
20
Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. a prospective population-based cohort.
J Alzheimers Dis
2011
0.90
21
Short- versus long-term prediction of dementia among subjects with low and high educational levels.
Alzheimers Dement
2012
0.87
22
Estimation of linear mixed models with a mixture of distribution for the random effects.
Comput Methods Programs Biomed
2005
0.86
23
Analysis of multivariate mixed longitudinal data: a flexible latent process approach.
Br J Math Stat Psychol
2012
0.83
24
Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measures.
J Biopharm Stat
2003
0.83
25
A Simulation Platform for Quantifying Survival Bias: An Application to Research on Determinants of Cognitive Decline.
Am J Epidemiol
2016
0.81
26
Quantifying and comparing dynamic predictive accuracy of joint models for longitudinal marker and time-to-event in presence of censoring and competing risks.
Biometrics
2014
0.81
27
Review and comparison of ROC curve estimators for a time-dependent outcome with marker-dependent censoring.
Biom J
2013
0.80
28
An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients.
HIV Clin Trials
2004
0.78
29
Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: Results from the personnes agées quid study.
J Am Geriatr Soc
2006
0.77
30
[Paquid 2012: illustration and overview].
Geriatr Psychol Neuropsychiatr Vieil
2012
0.77
31
Prevalence projections of chronic diseases and impact of public health intervention.
Biometrics
2013
0.76
32
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
J Acquir Immune Defic Syndr
2003
0.75
33
Analysis of undetectable HIV RNA using survival analysis: results must be interpreted carefully.
HIV Clin Trials
2003
0.75
34
Prognostic score for predicting risk of dementia over 10 years while accounting for competing risk of death.
Am J Epidemiol
2014
0.75